公司資料
Biodesix 股價、新聞與催化劑
- 股票代碼:
- BDSX
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
23.25 USD (-3.13%)
收盤價
最後更新: 2026年8月17日
160M USD
市值
股價為何變動
As of Aug 17, 2026, BDSX closed down 3.13% at $23.25. No new same-company headline was identified in the current news window.
公司概覽
Lung-Disease Diagnostics
Biodesix develops and commercializes diagnostic solutions intended to improve clinical decision-making, with a particular focus on lung disease and oncology. Its tests combine multiple analytical technologies with clinical evidence and laboratory operations.
Diagnostic Testing
The company provides blood-based and other diagnostic tests that help physicians characterize disease, guide treatment and monitor patients. Its commercial laboratory infrastructure supports ordering, sample processing and reporting for routine clinical use.
Development Services
Biodesix also works with biopharmaceutical, life-sciences and research organizations to develop diagnostics, tools and therapeutics. These services combine scientific, technological and operational capabilities and can support biomarker strategy from research through clinical development.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。